Czechia – Antineoplastic and immunomodulating agents – LP s obsahem irinotekanu 2026
Fakultní nemocnice Olomouc
AI Summary
Win probability: 25%Fakultní nemocnice Olomouc (Faculty Hospital Olomouc) is seeking supply of antineoplastic and immunomodulating agents, specifically irinotecan-containing products, for the 2026 period. This is a high-value pharmaceutical supplies contract worth approximately GBP/USD 6.47 million requiring qualified pharmaceutical distributors or manufacturers capable of supplying oncology medications to a major Czech teaching hospital. Eligibility typically requires EU/EEA registration, pharmaceutical licensing, compliance with Czech healthcare regulations, and ability to meet hospital procurement standards.
Similar tenders
Czechia – Software support services – Servisní podpora informačního systému ISEPA
Institut klinické a experimentální medicíny
€11,500,000
Czechia – Construction work – Stavba č. 44544 Terminál Smíchovské nádraží; stavební práce
HLAVNÍ MĚSTO PRAHA
€7,124,313,780
Czechia – Energy-efficiency consultancy services – PTK - Certifikace systému hospodaření s energií dle ČSN EN ISO 50001
Ředitelství silnic a dálnic s. p.
Applications are submitted on the official government portal. Minted Tenders helps you find and track opportunities — we don't process applications.
Details
- Source
- TED (EU)
- Country
- Czech Republic
- Type
- Tender
- Status
- Active
- Buyer
- Fakultní nemocnice Olomouc
- Value
- €6,473,820
- Deadline
- 24 Jun 2026
- Sectors
- supplies